Standout Papers

Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Dise... 2001 2026 2009 2017 1.1k
  1. Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease (2001)
    Christine M. Eng, Nathalie Guffon et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 21 from Science/Nature 50 standout
Sub-graph 1 of 21

Citing Papers

Arginine reprograms metabolism in liver cancer via RBM39
2023 Standout
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 Standout

Works of Philip Lee being referenced

Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression
2019

Author Peers

Author Last Decade Papers Cites
Philip Lee 1021 194 181 1378 720 63 3.4k
Ki-Han Kim 1658 14 53 745 336 143 3.9k
Keiichi Inoue 1931 53 47 532 394 95 4.1k
Kunihiko Suzuki 2988 101 38 3068 772 174 5.5k
Weiming Xu 3089 108 47 925 441 101 6.2k
Gregory R. Wojtkiewicz 1804 496 34 464 359 78 5.5k
Christian A. Combs 2567 244 55 699 875 73 5.4k
Claire Rodriguez‐Lafrasse 1904 486 13 783 275 124 4.1k
Damian E. Myers 2211 434 13 494 543 112 5.7k
Y. Eugene Chin 4130 166 42 519 504 98 7.6k
Evelyn Ralston 3065 91 140 1483 689 74 4.6k

All Works

Loading papers...

Rankless by CCL
2026